Evolution of immunity: The genomic link between Covid-19, Crohn’s disease and the Black Death
New research shows that the same genes that helped our ancestors survive the bubonic plague are still hard at work today
A ground-breaking new gene therapy has saved the life of its very first NHS patient
A baby girl is showing no further signs of the fatal genetic disorder metachromatic leukodystrophy after treatment with an exciting new gene therapy
A ‘world first’ in pre-emptive pharmacogenomic testing
Researchers show a 30% reduction in adverse reactions to common clinically prescribed drugs through pharmacogenomic testing
Base editing: What is it and what does it mean for healthcare?
This week, we take an in-depth look at the genome-editing technology that has been making headlines worldwide
Epigenomic studies spotlight new level of cancer evolution
While genomics sets the scene for cancer to grow, it isn’t the only actor – as shown by two studies that cast a light on the role of epigenomics
How epigenomic testing could improve cervical cancer detection
Introducing a new epigenomic test as part of routine cervical screening may help clinicians spot the signature of cervical cancer years before it develops
Cancer therapy involving genome editing cures another child’s leukaemia
We look at a new type of CAR-T cell therapy that, in the world’s first use, has cured a child patient’s leukaemia
Genomics on the horizon: Three predictions for 2023
To kick off the new year, we look at three areas of genomics research and advancement to watch out for in 2023 and beyond
Looking back: Genomics in 2022 (part two)
In the second and final part of our round-up of 2022, we look back at some of the milestones reached this year in genomics research
How can genomics combat doxorubicin-induced cardiotoxicity?
This week, we examine the role that genomics could play in reducing the number of child cancer patients who experience doxorubicin-induced cardiotoxicity
Genetics tool for check-ups described as a 'game changer'
Including polygenic risk scores for heart disease has been found to be a useful addition to NHS health checks that doesn’t affect GP workload
Liquid biopsy: What is it and why does it matter?
We take a look at the blood test that researchers hope could lead to earlier diagnosis of cancer